Allergy Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 9,944,213 | 0.208% |
General Public | 104,993,519 | 2.2% |
Public Companies | 126,904,345 | 2.66% |
Institutions | 130,365,220 | 2.73% |
Hedge Funds | 1,307,377,398 | 27.4% |
Private Companies | 3,096,703,576 | 64.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,096,703,576 | US$194.3m | 0% | no data | |||
1,307,377,398 | US$82.0m | 0% | 100.0% | |||
103,175,597 | US$6.5m | 0% | no data | |||
37,900,000 | US$2.4m | 0% | no data | |||
13,877,871 | US$870.7k | 0% | 0.02% | |||
13,610,000 | US$853.9k | 70.1% | no data | |||
13,563,087 | US$851.0k | 1.85% | 0.01% | |||
10,118,748 | US$634.9k | 0% | no data | |||
9,832,263 | US$616.9k | 15.9% | no data | |||
9,641,528 | US$604.9k | -8.87% | 0.05% | |||
5,384,603 | US$337.9k | 109% | no data | |||
5,001,200 | US$313.8k | 0% | no data | |||
4,723,420 | US$296.3k | -1.37% | no data | |||
4,680,000 | US$293.6k | 0% | no data | |||
4,532,044 | US$284.4k | -5.03% | no data | |||
4,205,533 | US$263.9k | 0% | no data | |||
4,022,151 | US$252.4k | 3.15% | 0.02% | |||
3,095,575 | US$194.2k | -14.3% | 0.01% | |||
2,100,000 | US$131.8k | 0% | no data | |||
1,925,000 | US$120.8k | 0% | no data | |||
1,717,057 | US$107.7k | 36.3% | no data | |||
1,428,650 | US$89.6k | 18.1% | no data | |||
1,421,545 | US$89.2k | 0% | 0.05% | |||
1,400,000 | US$87.8k | 0% | 0.01% | |||
1,164,102 | US$73.0k | -2.11% | no data |